These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 27706833)
1. Pancreatic adenocarcinoma up-regulated factor has oncogenic functions in oral squamous cell carcinoma. Sasahira T; Kurihara M; Nishiguchi Y; Nakashima C; Kirita T; Kuniyasu H Histopathology; 2017 Mar; 70(4):539-548. PubMed ID: 27706833 [TBL] [Abstract][Full Text] [Related]
2. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma. Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of DHRS9 is associated with poor prognosis in oral squamous cell carcinoma. Shimomura H; Sasahira T; Nakashima C; Shimomura-Kurihara M; Kirita T Pathology; 2018 Oct; 50(6):642-647. PubMed ID: 30149992 [TBL] [Abstract][Full Text] [Related]
4. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma. Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828 [TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma. Kang Y; Zhang Y; Sun Y Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958 [TBL] [Abstract][Full Text] [Related]
6. The level and clinical significance of 5-hydroxymethylcytosine in oral squamous cell carcinoma: An immunohistochemical study in 95 patients. Wang Y; Hu H; Wang Q; Li Z; Zhu Y; Zhang W; Wang Y; Jiang H; Cheng J Pathol Res Pract; 2017 Aug; 213(8):969-974. PubMed ID: 28554766 [TBL] [Abstract][Full Text] [Related]
7. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma. Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894 [TBL] [Abstract][Full Text] [Related]
8. FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma. Wen Q; Alnemah MM; Luo J; Wang W; Chu S; Chen L; Li J; Xu L; Li M; Zhou J; Fan S Int J Clin Exp Pathol; 2015; 8(7):8236-43. PubMed ID: 26339392 [TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma. Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663 [TBL] [Abstract][Full Text] [Related]
11. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage. Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398 [TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma. Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492 [TBL] [Abstract][Full Text] [Related]
13. Circulating CD105 shows significant impact in patients of oral cancer and promotes malignancy of cancer cells via CCL20. Chen CH; Chuang HC; Lin YT; Fang FM; Huang CC; Chen CM; Lu H; Chien CY Tumour Biol; 2016 Feb; 37(2):1995-2005. PubMed ID: 26334621 [TBL] [Abstract][Full Text] [Related]
14. Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype. Satgunaseelan L; Gupta R; Madore J; Chia N; Lum T; Palme CE; Boyer M; Scolyer RA; Clark JR Pathology; 2016 Oct; 48(6):574-80. PubMed ID: 27590194 [TBL] [Abstract][Full Text] [Related]
15. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis. Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma. Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810 [TBL] [Abstract][Full Text] [Related]
17. Association of pancreatic adenocarcinoma up-regulated factor expression in ovarian mucinous adenocarcinoma with poor prognosis. Kim SK; Song SY; Kim S; Cho NH; Yim GW; Kim SW; Kim YT; Nam EJ Int J Clin Exp Pathol; 2014; 7(8):5103-10. PubMed ID: 25197383 [TBL] [Abstract][Full Text] [Related]
18. SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma. Yoon TM; Kim SA; Cho WS; Lee DH; Lee JK; Park YL; Lee KH; Lee JH; Kweon SS; Chung IJ; Lim SC; Joo YE BMC Cancer; 2015 Nov; 15():888. PubMed ID: 26555193 [TBL] [Abstract][Full Text] [Related]
19. p16 expression independent of human papillomavirus is associated with lower stage and longer disease-free survival in oral cavity squamous cell carcinoma. Satgunaseelan L; Virk SA; Lum T; Gao K; Clark JR; Gupta R Pathology; 2016 Aug; 48(5):441-8. PubMed ID: 27370365 [TBL] [Abstract][Full Text] [Related]
20. A decreased peritumoral CD1a+ cell number predicts a worse prognosis in oral squamous cell carcinoma. Jardim JF; Gondak R; Galvis MM; Pinto CAL; Kowalski LP Histopathology; 2018 May; 72(6):905-913. PubMed ID: 29023924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]